SurModics Targets More Drug Delivery Devices, Signs Second Stent Maker
This article was originally published in The Gray Sheet
Executive Summary
SurModics is building on its polymer licensing agreement with Johnson & Johnson/Cordis, reaching a similar deal with a second stent player while pursuing broader uses for the coating